We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Lateral-Flow Assay Identifies Legionella

By HospiMedica staff writers
Posted on 09 Oct 2006
A new rapid lateral-flow assay enables the simultaneous identification of all Legionella species. More...
The most prominent species, Legionella pneumophila, can be identified separately using the same assay.

The new test, called Duopath Legionella, is available from Merck KGaA (Darmstadt, Germany). It can be used for confirmation of suspect colonies obtained after enrichment of water or environmental samples on buffered charcoal yeast extract (BCYE) agar medium or BCYE with Legionella-selective supplements. The test is highly sensitive and lowers the risk of false-negative results. In a comparative study with the widely used latex-agglutination assay, the sensitivity of Duopath Legionella was shown to be 100% for Legionella pneumophila and 92% for Legionella species, while the latex assay provided only 98% and 37%, respectively.

All warm water samples that are not heated above 56°C are potential sources of Legionella. Thus, water systems in institutions such as hospitals, nursing homes, and schools are frequently analyzed for the presence of Legionella. Some countries require water testing for the presence of Legionella pneumophila, but many countries require analysis for all Legionella species. Duopath Legionella can be used by microbiology laboratories that analyze water samples from various sources (e.g., drinking water from water pipes, warmed pool or shower water, water from cooling towers, and air conditioners).

The assay extends Merck's Singlepath/Duopath lateral-flow program for the rapid and convenient detection and confirmation of Salmonella, Listeria spp., Escherichia coli O157, verotoxin-producing E coli, and Campylobacter. Duopath Legionella is perfectly adapted to Merck's range of culture media for the enrichment of Legionellae.



Related Links:
Merck

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.